Nalbuphine Hydrochloride (Cardinal Health)


Welcome to the PulseAid listing for the Nalbuphine Hydrochloride drug offered from Cardinal Health. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: Nalbuphine Hydrochloride
SUBSTANCE NAME: NALBUPHINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1989-02-03
END MARKETING DATE: 0000-00-00


Nalbuphine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNalbuphine Hydrochloride from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 1989-02-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-3198_9ad5e836-33bf-49c9-a530-296cff30d1c7
PRODUCT NDC: 55154-3198
APPLICATION NUMBER: ANDA070914

Other NALBUPHINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthNalbuphine Hydrochloride
General Injectables & Vaccines, IncNalbuphine Hydrochloride
Hospira, Inc.Nalbuphine Hydrochloride
McKesson Packaging Services Business Unit of McKesson CorporationNalbuphine Hydrochloride